Denali Therapeutics Inc. (DNLI)
NASDAQ·Healthcare·Biotechnology
$23.76
-1.25%
Mkt Cap $3.78B
Analyst Ratings
Buy
16
Hold
0
Sell
0
Price Target (21 analysts)
$34.60
Range $26.00 – $41.00
Implied Upside
+45.6%
Consensus $34.60 vs current $23.76
NASDAQ·Healthcare·Biotechnology
$23.76
-1.25%
Mkt Cap $3.78B
Buy
16
Hold
0
Sell
0
Price Target (21 analysts)
$34.60
Range $26.00 – $41.00
+45.6%
Consensus $34.60 vs current $23.76